MATTHEW D HULSEY
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- GLENWOOD, AR
- NPI
- 1275573750
- Received
- $1,107 in 44 records, 2019 to 2025
- As principal investigator
- $21,730 of research payments to others in 3 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 5 | $78 |
| 2024 | General payment | 10 | $307 |
| 2023 | General payment | 8 | $245 |
| 2022 | General payment | 6 | $116 |
| 2021 | General payment | 2 | $90 |
| 2020 | General payment | 9 | $129 |
| 2019 | General payment | 4 | $139 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Procept Biorobotics Corporation | 1 | $156 | 2024 |
| AstraZeneca Pharmaceuticals LP | 4 | $152 | 2023–2024 |
| Exact Sciences Corporation | 8 | $138 | 2023–2025 |
| Hologic Sales and Service, LLC | 1 | $99 | 2019 |
| ABBVIE INC. | 2 | $98 | 2021–2023 |
| PFIZER INC. | 5 | $84 | 2020–2023 |
| Amgen Inc. | 5 | $82 | 2020–2025 |
| Abbott Laboratories | 3 | $65 | 2021–2022 |
| GlaxoSmithKline, LLC. | 3 | $53 | 2020–2022 |
| Novo Nordisk Inc | 3 | $44 | 2019–2024 |
| Janssen Pharmaceuticals, Inc | 2 | $32 | 2020 |
| Lilly USA, LLC | 2 | $24 | 2020 |
| Phadia US Inc. | 1 | $20 | 2023 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 | 2025 |
| Merck Sharp & Dohme LLC | 1 | $15 | 2022 |
| Allergan, Inc. | 1 | $13 | 2019 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $11 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 44 | $1,107 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-20 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-08-27 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | The Cologuard Plus Collection Kit Device, Oncology | 2025 | |
| 2025-04-23 | Exact Sciences Corporation | $18 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2025 | |
| 2025-03-04 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | OTEZLA Drug, Inflammation | 2025 | |
| 2025-01-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2024-12-11 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-10-08 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-09-30 | Exact Sciences Corporation | $16 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-07-23 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-06-25 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-23 | Exact Sciences Corporation | $16 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-03-28 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-03-07 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2024 | |
| 2024-02-20 | Exact Sciences Corporation | $18 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-02-13 | Procept Biorobotics Corporation | $156 | Food and Beverage | Cash or cash equivalent | AQUABEAM SYSTEM Device, UROLOGY | 2024 | |
| 2023-11-01 | Exact Sciences Corporation | $17 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2023 | |
| 2023-10-25 | AstraZeneca Pharmaceuticals LP | $103 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-04 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | TRUMENBA Biological, VACCINES | 2023 | |
| 2023-08-31 | Phadia US Inc. | $20 | Food and Beverage | Cash or cash equivalent | ImmunoCAP Device, Allergy/Immunology | 2023 | |
| 2023-08-28 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-27 | Exact Sciences Corporation | $17 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2023 | |
| 2023-07-20 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | TRUMENBA Biological, VACCINES | 2023 | |
| 2023-04-19 | Exact Sciences Corporation | $18 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2023 | |
| 2022-10-27 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | PREVNAR 13 Biological, VACCINES | 2022 | |
| 2022-09-20 | Abbott Laboratories | $24 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-07-06 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | GARDASIL 9 Biological, VACCINE | 2022 | |
| 2022-04-20 | Abbott Laboratories | $21 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-03-31 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-01-28 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2022 | |
| 2021-12-02 | ABBVIE INC. | $70 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-20 | Abbott Laboratories | $19 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2020-12-02 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2020 | |
| 2020-11-12 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2020 | |
| 2020-10-21 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2020 | |
| 2020-10-15 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | BASAGLAR Drug, Diabetes | 2020 | |
| 2020-10-13 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2020 | |
| 2020-09-11 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2020 | |
| 2020-05-07 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2020 | |
| 2020-03-04 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2020 | |
| 2020-01-09 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2020 | |
| 2019-09-30 | Hologic Sales and Service, LLC | $99 | Food and Beverage | In-kind items and services | Cervical Cancer Screening Device, Diagnostics | 2019 | |
| 2019-09-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $11 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2019 | |
| 2019-08-15 | Allergan, Inc. | $13 | Food and Beverage | In-kind items and services | BYSTOLIC Drug, CARDIOVASCULAR | 2019 | |
| 2019-07-16 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Tresiba Drug, Diabetes | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-31 | ABBVIE INC. | HEALTHSTAR RESEARCH | $830 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-attack Study to Evaluate the Efficacy, Safe | 2025 |
| 2025-10-09 | ABBVIE INC. | HEALTHSTAR RESEARCH LLC | $10,450 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch | 2025 |
| 2025-10-09 | ABBVIE INC. | HEALTHSTAR RESEARCH LLC | $10,450 | Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migrai | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Glenwood, AR, county Pike County, AR, state Arkansas; placed by its city name.
| Measure | Place (city or town) Glenwood, AR | County Pike County, AR | State Arkansas |
|---|---|---|---|
| Population B01003 | 1,841 | 10,115 | 3,049,391 |
| Population, 2020 census P1 | 2,068 | 10,171 | 3,011,524 |
| Median age B01002 | 35.6 | 41.2 | 38.5 |
| Under 18 B01001 | 24.4% | 22.3% | 23.1% |
| 65 and over B01001 | 19.1% | 21.0% | 17.6% |
| Households B11001 | 770 | 4,082 | 1,205,987 |
| Foreign born B05002 | 17.3% | 4.2% | 5.4% |
| Median household income B19013 | $33,500 | $49,269 | $60,773 |
| Median family income B19113 | $43,500 | $68,086 | $76,968 |
| Per capita income B19301 | $21,540 | $30,240 | $34,225 |
| Poverty rate B17001 | 38.8% | 20.7% | 16.0% |
| Unemployment rate B23025 | 1.0% | 3.9% | 4.9% |
| Civilian labor force B23025 | 698 | 4,128 | 1,411,269 |
| Mean commute (minutes) B08013 | 18.4 | 29.9 | 22.5 |
| Bachelor's degree or higher B15003 | 15.1% | 19.1% | 25.7% |
| Housing units B25001 | 875 | 5,324 | 1,394,673 |
| Owner-occupied B25003 | 56.5% | 75.0% | 66.4% |
| Renters B25003 | 43.5% | 25.0% | 33.6% |
| Median home value B25077 | $132,500 | $121,600 | $188,000 |
| Median gross rent B25064 | $664 | $686 | $947 |
| White, not Hispanic B03002 | 67.0% | 83.4% | 67.4% |
| Black B03002 | 1.1% | 3.3% | 14.6% |
| Hispanic or Latino B03002 | 29.2% | 8.0% | 9.0% |
| Asian B03002 | 1.4% | 0.5% | 1.6% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.3% |
Economy now FRED unemployment 3.9% in Sep 2026 (4.2% a year earlier); per capita personal income $61,697 in 2025, up 31% in five years (+5.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Glenwood, AR.
Comments